The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Rima Jaber, Ph.D., Lauren Longobardi, Ph.D., and Sebastian Detlefsen, Dr.-Ing. of Evonik discuss the importance of lipid nanoparticle purity and design in the delivery of mRNA-based vaccines and therapeutics and how Evonik develops optimal proprietary lipids to ensure the highest-performing nucleotide vaccines and therapeutics.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: